NCT00419146: Treatment of Schizophrenia With an Omega-3 Fatty Acid (EPA) and Antioxidants |
|
|
| Completed | 2/3 | 99 | Europe | Ethyl-eicosapentaenoic acid (EPA), Provided by Laxdale Ltd., Scotland, UK, Vitamins E + C, CellaVie (Ferrosan AS, Denmark), Etyl EPA (placebo), Placebo EPA, Vitamins E+C (placebo), Placebo CellaVie, provided by Ferrosan AS, Denmark | University Hospital, Aker, Diakonhjemmet Hospital, Stanley Medical Research Institute, Laxdale Ltd, Scandinavian Society for Psychopharmacology, Shipowner Emil Stray's legacy, Johanne and Einar Eilertsen's research fund, AstraZeneca, Solveig and Johan P. Sommer's foundation, Josef and Haldis Andresen's legacy, University of Oslo, Norwegian University of Science and Technology | Schizophrenia, Schizophreniform Disorders, Schizoaffective Disorder, Psychotic Disorders | 04/04 | 04/04 | | |
